Temporal trends in the black/white breast cancer case ratio for estrogen receptor status: Disparities are historically contingent, not innate

Cancer Causes and Control

Volumn 22, Issue 3, 2011, Pages 511-514

  Krieger, Nancy ^a   Chen, Jarvis T ^a   Waterman, Pamela D ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Black; Breast cancer; Cancer disparities; Estrogen receptor; Social determinants of health; White

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGE; ARTICLE; BREAST CANCER; CANCER REGISTRY; CAUCASIAN; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; TIME;

AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; RECEPTORS, ESTROGEN; REGISTRIES; SEER PROGRAM; UNITED STATES;

EID: 79955783557     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-010-9710-7     Document Type: Article

References (25)

1. Natrajan N, Nemoto T, Mettlin C, Murphy GP (1985) Racerelated differences in breast cancer patients: Results of the 1982 National Survey of Breast Cancer by the American College of Surgeons. Cancer 56:1704-1709 (Pubitemid 15228525)
2. Pegoraro RJ, Karnan V, Nirmul D, Joubert SM (1986) Estrogen and progesterone receptors in breast cancer among women of different racial groups. Cancer Res 46:2117-2120 (Pubitemid 16117918)
3. Elledge RM, Clark GM, Chamness GC et al (1994) Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. JNCI 86:705-712 (Pubitemid 24138977)
4. Joslyn SA (2002) Hormone receptors in breast cancer: Racial differences in distribution and survival. Breast Cancer Res Treat 73:45-59 (Pubitemid 34548165)
5. Morris GJ, Naidu S, Topham AK et al (2007) Differences in breast carcinoma characteristics in newly diagnosed African- American and Caucasian patients: A single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results Database. Cancer 110:876-884 (Pubitemid 47257667)
6. Banks E, Canfell K (2010) Recent declines in breast cancer incidence: Mounting evidence that reduced use of menopausal hormones is largely responsible. Breast Cancer Res 12:103. http://breast-cancer-research.com/12/1/ 103
7. Chlebowski RT, Kuller LH, Prentice RL et al (2009) Breast cancer after use of estrogen plus progestin in postmenopausal women. New Engl J Med 360:573-587
8. Writing Group for the Women's Health Initiative Investigators (2002) Risk and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333
9. Friedman-Koss D, Crespo CJ, Bellantoni MF, Andersen RE (2002) The relationship of race/ethnicity and social class to hormone replacement therapy: Results from the Third National Health and Nutrition Examination Survey 1988-1994. Menopause 9:264-272 (Pubitemid 34743451)
10. Chlebowski RT, Chen Z, Anderson GL et al (2005) Ethnicity and breast cancer: Factors influencing differences in incidence and outcome. J Natl Cancer Inst 97:439-448
11. Krieger N, Chen JT, Waterman PD (2010) Decline in US breast cancer rates after the women's health initiative: Socioeconomic and racial/ethnic differentials. Am J Public Health 100: S132-139 [epub advance access: 10 Feb 2010]. doi:10.2105/AJPH.2009. 181628; NIHMS # 171687
12. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Limited-Use Data (1973-2005), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2008, based on the November 2007 submission. http://seer.cancer.gov/data/index. html. Accessed 3 August 2009
13. Anderson RN, Rosenberg HM (1998) Age standardization of death rates: Implementation of the year 2000 standard. Natl Vital Stat Rep 37(3)
14. Kim H-J, Fay MP, Yu B, Barrett MJ, Feuer EJ (2004) Comparability of segmented line regression models. Biometrics 60: 1005-1014 (Pubitemid 40019042)
15. Dietel M, Lewis MA, Shapiro S (2005) Hormone replacement therapy: Pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: A minireview. Hum Reprod 20:2052-2060 (Pubitemid 41418488)
16. Kunitz S (2006) The health of populations: General theories and particular realities. Oxford University Press, Oxford
17. Krieger N, Davey Smith G (2004) Bodies count & body counts: Social epidemiology & embodying inequality. Epidemiol Rev 26: 92-103 (Pubitemid 38856479)
18. Graham H (1996) Smoking prevalence among women in the European community 1950-1990. Soc Sci Med 43:243-254 (Pubitemid 26254065)
19. Brandt A (2007) The cigarette century: The rise, fall, and deadly persistence of the product that defined America. Basic Books, New York
20. National Center for Health Statistics (2009) Health, United States 2009. Table 36: Death rates for malignant neoplasm of breast among females, by race, Hispanic origin, and age: United States, selected years 1950-2006. National Center for Health Statistics, Hyattsville, p 224
21. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards BK (eds) (2010) SEER cancer statistics review, 1975-2006. National Cancer Institute, Bethesda. Available at: Http://seer.cancer.gov/ csr/1975-2006/, based on November 2008 SEER data submission, posted to the SEER web site, 2009; see: Table 4.6. Cancer of the breast (Invasive). Age-adjusted US death rates by year, race, and sex. Available at: Http://seer.cancer.gov/csr/ 1975-2006/ results-merged/sect-04-breast.pdf. Accessed 3 June 2010
22. Krieger N, Chen JT, Ware JH, Kaddour A (2008) Race/ethnicity and breast cancer estrogen receptor status: Impact of class, missing data, & modeling assumptions. Cancer Causes Control 19:1305-1318. doi:10.1007/s10552-008-9202-1
23. Krieger N, Emmons K, Williams D (2009) Defining, investigating, and addressing cancer inequities: Critical issues. In: Koh H (ed) Toward the elimination of cancer disparities: A clinical and public health perspective. Springer, New York, pp 3-28
24. Krieger N (ed) (2004) Embodying inequality: Epidemiologic perspectives. Baywood Publishing Co, Amityville
25. Gravlee CC (2009) How race becomes biology: Embodiment of social inequality. Am J Phys Anthropol 139:47-57